Follow
Roger Mulet Lazaro
Roger Mulet Lazaro
Postdoctoral researcher, Erasmus Medical Center
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
F Taube, JA Georgi, M Kramer, S Stasik, JM Middeke, C Röllig, U Krug, ...
Blood, The Journal of the American Society of Hematology 139 (1), 87-103, 2022
1032022
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia
S Ottema, R Mulet-Lazaro, HB Beverloo, C Erpelinck, S van Herk, ...
Blood, The Journal of the American Society of Hematology 136 (2), 224-234, 2020
492020
PopHuman: the human population genomics browser
S Casillas, R Mulet, P Villegas-Miron, S Hervas, E Sanz, D Velasco, ...
Nucleic acids research 46 (D1), D1003-D1010, 2018
402018
Novel neuroprotective multicomponent therapy for amyotrophic lateral sclerosis designed by networked systems
M Herrando-Grabulosa, R Mulet, A Pujol, JM Mas, X Navarro, P Aloy, ...
PLoS One 11 (1), e0147626, 2016
382016
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops
S Ottema, R Mulet-Lazaro, C Erpelinck-Verschueren, S van Herk, ...
Nature Communications 12 (1), 5679, 2021
352021
Selective requirement of MYB for oncogenic hyperactivation of a translocated enhancer in leukemia
L Smeenk, S Ottema, R Mulet-Lazaro, A Ebert, M Havermans, AA Varea, ...
Cancer discovery 11 (11), 2868-2883, 2021
292021
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML
R Mulet-Lazaro, S van Herk, C Erpelinck, E Bindels, MA Sanders, ...
Blood, The Journal of the American Society of Hematology 138 (2), 160-177, 2021
172021
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
A Tanaka, TA Nakano, M Nomura, H Yamazaki, JP Bewersdorf, ...
Blood, The Journal of the American Society of Hematology 140 (8), 875-888, 2022
162022
Systems biology applied to non-alcoholic fatty liver disease (NAFLD): treatment selection based on the mechanism of action of nutraceuticals
S Perera, L Artigas, R Mulet, JM Mas, T Sardón
Nutrafoods 13, 61-68, 2014
132014
Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
R Avellino, R Mulet-Lazaro, M Havermans, R Hoogenboezem, L Smeenk, ...
Blood advances 6 (5), 1406-1419, 2022
42022
Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency
A Rein, I Geron, E Kugler, H Fishman, E Gottlieb, I Abramovich, A Giladi, ...
Haematologica 108 (9), 2316, 2023
32023
Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype
C Gebhard, R Mulet-Lazaro, D Glatz, L Schwarzfischer-Pfeilschifter, ...
International journal of cancer, 2021
32021
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
R Mulet-Lazaro, S van Herk, M Nuetzel, A Sijs-Szabo, N Díaz, K Kelly, ...
Nature Communications 15 (1), 5693, 2024
2024
Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2
D Pastoors, M Havermans, R Mulet-Lazaro, D Brian, W Noort, J Grasel, ...
Science Advances 10 (20), eadk9076, 2024
2024
Tumor-specific super-enhancer drives overexpression of EVI1 in ovarian cancer
L Smeenk, S Kruse, R Mulet-Lazaro, I Boere, J Martens, S Gröschel, ...
Cancer Research 84 (6_Supplement), 3040-3040, 2024
2024
Targeting Super-Enhancers Driving EVI1 Expression in Leukemia By Inhibition of p300/CBP
D Pastoors, C Erpelinck, S Van Herk, R Mulet-Lazaro, M Havermans, ...
Blood 142, 710, 2023
2023
From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in Hematopoiesis
R Mulet-Lazaro, R Delwel
HemaSphere 7 (11), e969, 2023
2023
Cohesin-STAG2 Mutations Alter Chromatin Structure and Gene Regulation in Human Acute Myeloid Leukemia
A Fischer, R Mulet-Lazaro, M Nützel, S van Herk, H Stanewsky, ...
Blood 140 (Supplement 1), 3379-3380, 2022
2022
Oncogene EVI1 Drives Acute Myeloid Leukemia Via a Targetable EVI1-CtBP1/2 Interaction and By Repressing Myeloid Regulator CEBPA
D Pastoors, M Havermans, R Hoogenboezem, R Mulet-Lazaro, D Brian, ...
Blood 140 (Supplement 1), 83-84, 2022
2022
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML (vol 138, pg 160, 2021)
R Mulet-Lazaro, S van Herk, C Erpelinck
BLOOD 139 (11), 1772-1772, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20